Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Al­bu­mins

Albumins belong to the group of plasma proteins. Albumins serve as transport proteins in the blood and are responsible for the colloid osmotic pressure of blood plasma. They are, for instance, used to stabilize the blood circulation volume in the event of strong bleeding.

Name Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date Further Information

Al­biomin 5%

Biotest Phar­ma GmbH

PEI.H.03575.01.1 22.06.2007

Al­biomin 20%

Biotest Phar­ma GmbH

PEI.H.03574.01.1 22.06.2007

Al­bume­on

CSL Behring GmbH

PEI.H.11655.01.1 24.05.2013

Al­bunorm 4%

Oc­taphar­ma GmbH

PEI.H.04333.05.1 20.07.2015

Al­bunorm 5%

Oc­taphar­ma GmbH

PEI.H.04333.01.1 26.03.2009

Al­bunorm 20%

Oc­taphar­ma GmbH

PEI.H.04333.02.1 26.03.2009

Al­bunorm 25%

Oc­taphar­ma GmbH

PEI.H.04333.06.1 20.07.2015

Al­bu­rex 5

CSL Behring GmbH

PEI.H.11429.01.1 25.01.2010

Al­bu­rex 20

CSL Behring GmbH

PEI.H.11429.02.1 25.01.2010

Al­butein 50 g/l

Gri­fols Deutsch­land GmbH

PEI.H.12090.01.1 26.08.2021

Al­butein 200 g/l

Gri­fols Deutsch­land GmbH

PEI.H.12090.02.1 26.08.2021

Cre­alb 200g/l

Pro­thya Bioso­lu­tions Nether­lands B.V.

PEI.H.12044.02.1 24.09.2020

HU­MAN AL­BU­MIN 50g/l Bax­al­ta

Take­da GmbH

PEI.H.03271.01.1 01.04.2006

HU­MAN AL­BU­MIN 200g/l Bax­al­ta

Take­da GmbH

PEI.H.03272.01.1 01.04.2006

HU­MAN AL­BU­MIN 250g/l Bax­al­ta

Take­da GmbH

PEI.H.03273.03.1 12.10.2023

Hu­man-Al­bu­min 20% Behring, salzarm

CSL Behring GmbH

10530a/96 27.01.1997

Hu­manal­bin

CSL Behring GmbH

10531a/96 09.02.1999

Hu­manal­bu­min 200 g/l Kedri­on

KEDRI­ON S.p.A.

PEI.H.02994.01.1 12.12.2003

Plas­bu­min 20

Gri­fols Deutsch­land GmbH

4962.01.00 06.08.1984

Plas­bu­min 25

Gri­fols Deutsch­land GmbH

10537a/96 26.05.1999

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 514 in BAnz AT 01.03.2024 B8.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 04.03.2024